| Inhibitors of the Zika virus protease NS2B-NS3 S Voss, C Nitsche Bioorganic & medicinal chemistry letters 30 (5), 126965, 2020 | 73 | 2020 |
| Peptide–bismuth bicycles: In situ access to stable constrained peptides with superior bioactivity S Voss, J Rademann, C Nitsche Angewandte Chemie International Edition 61 (4), e202113857, 2022 | 31 | 2022 |
| Targeting the protease of West Nile virus S Voss, C Nitsche RSC Medicinal Chemistry 12 (8), 1262-1272, 2021 | 14 | 2021 |
| Cell‐Penetrating Peptide‐Bismuth Bicycles S Voss, LD Adair, K Achazi, H Kim, S Bergemann, R Bartenschlager, ... Angewandte Chemie International Edition 136 (10), e202318615, 2024 | 10 | 2024 |
| Characterisation of ten NS2B-NS3 proteases: Paving the way for pan-flavivirus drugs S Voss, J Rademann, C Nitsche Antiviral Research, 105878, 2024 | 6 | 2024 |
| Exploring biocompatible chemistry to create stapled and photoswitchable variants of the antimicrobial peptide aurein 1.2 AE Coram, R Morewood, S Voss, JL Price, C Nitsche Journal of Peptide Science, e3551, 2023 | 4 | 2023 |
| rsc. li/medchem ID Iyamu, R Huang, S Voss, C Nitsche | | |